Optimisation and Quantification of Contrast Enhanced Computed Tomography Myocardial Fibrosis Imaging
This trial is active, not recruiting.
|Treatment||computed tomography late enhancement imaging|
|Sponsor||University of Edinburgh|
|Start date||October 2013|
|End date||December 2015|
|Trial size||40 participants|
|Trial identifier||NCT02364687, 13/SS/0152|
Detecting scarred heart muscle is important to diagnose and treat of a wide variety of heart conditions. Magnetic resonance imaging (MRI) can assess scarred heart muscle but it is time consuming, contraindicated for some patients and not tolerated by others. Computed tomography (CT) imaging has the potential to provide a rapid comprehensive assessment of the heart. This study will assess CT imaging of the heart muscle of patients who have previously undergone MRI of their heart. Using a state of the art CT scanner we will develop a low radiation dose protocol to identify scarred heart muscle. We will use and develop software techniques to analyse these images. This will enable us to develop a new way to identify and measure scarred heart muscle that will benefit patients with heart disease.
Participants will have previously had an MRI scan and will undergo a CT scan.
Myocardial late enhancement
time frame: Immediate
Male or female participants at least 40 years old.
Inclusion Criteria: - Presence of late enhancement on magnetic resonance imaging Exclusion Criteria: - age less than 40 - inability or unwillingness to undergo CT - renal failure (serum creatinine >200 umol/l or estimated glomerular filtration rate <30 ml/min) - hepatic failure - allergy to iodinated contrast - pregnancy - breast feeding - inability to undergo informed consent - fast atrial fibrillation
|Official title||Optimisation and Quantification of Contrast Enhanced Computed Tomography|
|Principal investigator||Michelle Williams|
Call for more information